Does familiarity with the paper informed consent process mean that it is the best way? Think that there are no benefits to switching to eConsent? Read about some common myths and follow links to helpful resources.
Myth number 5: Pharmaceutical companies are not using eConsent.
Myth number 6: Paper consents are preferred by sites.
Myth number 7: Subject participation in the consent process is not improved with eConsent.
Do you think you understand all there is to know about eConsent? Explore more common myths about eConsent when you sign up for CRF Health’s blog series here.
-The Clinical Pathways Team
Enjoy this blog? Please like, comment, and share with your contacts.